Sequential serum samples obtained from 50 rheumatic fever subjects and from control individuals matched for time, age and geographical location were tested for antibodies against the M-associated protein antigens, MAP I and MAP II. Antibody titres were determined by the complement fixation test with a partially-purified extract of Streptococcus pyogenes serotype M30 as the MAP I antigen and an acid extract of serotype M48 as the MAP II antigen. Titres of MAP I antibody exceeded those of MAP II antibody in all but six rheumatic fever subjects. Anti-MAP I titres in excess of 40 were significantly more common in rheumatic fever subjects than in matched controls (p < 0.001) or matched subjects with a diagnosis of acute post-streptococcal glomerulonephritis (p < 0.01). Peak MAP I titres were present at the time of admission to hospital in the sera of 40 of the 50 rheumatic fever subjects. In the remainder peak titres occurred within 10 days. Antibody titres were maintained for a mean of 10.3 weeks before declining. Changes in MAP antibody titres were independent of changes in antistreptolysin O and anti-DNAase B titres. Normal children aged between 6 and 15 had higher MAP antibody titres than 2-5-year-old children. Rheumatic fever subjects had significantly higher mean titres of MAP I antibody than matched controls in each age group.
AyoubE. M.,
WannamakerL. W.1962; Evaluation of the streptococcal desoxyribonuclease B and diphosphopyridine nucleotidase antibody tests in acute rheumatic fever and acute glomerulonephritis. Pediatrics 29:527–538
BeacheyE. H.,
OfekI.,
BisnoA. L.1973; Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. Journal of Immunology 111:1361–1366
DawsonK. P.,
MartinD. R.1982; Streptococcal involvement in childhood acute glomerulonephritis: a review of 20 cases at admission. New Zealand Medical Journal 95:373–376
GuirguisN.,
FraserD. W.,
FacklamR. R.,
El KholyA.,
WannamakerL. W.1982; Type-specific immunity and pharyngeal acquisition of group A streptococcus. American Journal of Epidemiology 116:933–939
NelsonJ.,
AyoubE. M.,
WannamakerL. W.1968; Streptococcal anti-deoxyribonuclease B: microtechnique determination. Journal of Laboratory and Clinical Medicine 71:867–873
SiegelA. C.,
JohnsonE. E.,
StollermanG. H.1961; Controlled studies of streptococcal pharyngitis in a pediatric population. 2. Behaviour of the type-specific immune response. New England Journal of Medicine 265:566–571
VostiK. L.,
JohnsonmR. H.,
DillonM. F.1971; Further characterizaton of purified fractions of M protein from a strain of group A type 12 streptococcus. Journal of Immunology 107:104–114
WiddowsonJ. P.1980; The M-associated protein antigens of group A streptococci. In
ReadS. E.,
ZabriskieJ. B.
(eds) Streptococcal disease and the immune response Academic Press; New York: pp 125–147
WiddowsonJ. P.,
MaxtedW. R.,
NotleyC. M.,
PinneyA. M.1974; The antibody responses in man to infection with different serotypes of group-A streptococci. Journal of Medical Microbiology 7:483–496
WiddowsonJ. P.,
MaxtedW. R.,
PinneyA. M.1976; Immunological heterogeneity among the M-associated protein antigens of group-A streptococci. Journal of Medical Microbiology 9:73–88